Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Idorsia Ltd is a Swiss biopharmaceutical company based in Allschwil near Basel. Spun off from Actelion in 2017, it discovers and develops small-molecule drugs across a range of therapeutic areas. Its shares are listed on the SIX Swiss Exchange.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Idorsia is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Idorsia last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.17 CHF.
Idorsia has beaten analyst EPS estimates in 2 of its last 4 evaluated quarters (beat rate: 50%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.